DK1710241T3 - Intermediatforbindelser til fremstilling af trans-5-chlor-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,7]oxepino[4,5-c]pyrrol - Google Patents

Intermediatforbindelser til fremstilling af trans-5-chlor-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,7]oxepino[4,5-c]pyrrol

Info

Publication number
DK1710241T3
DK1710241T3 DK06112333.7T DK06112333T DK1710241T3 DK 1710241 T3 DK1710241 T3 DK 1710241T3 DK 06112333 T DK06112333 T DK 06112333T DK 1710241 T3 DK1710241 T3 DK 1710241T3
Authority
DK
Denmark
Prior art keywords
oxepino
dibenz
pyrrole
tetrahydro
trans
Prior art date
Application number
DK06112333.7T
Other languages
English (en)
Inventor
Gerardus Johannes Kemperman
Der Linden Jacobus Johannes Van
Michael R Reeder
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Application granted granted Critical
Publication of DK1710241T3 publication Critical patent/DK1710241T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D313/00Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02Seven-membered rings
    • C07D313/06Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/10Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D313/14[b,f]-condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrane Compounds (AREA)
DK06112333.7T 2005-04-07 2006-04-06 Intermediatforbindelser til fremstilling af trans-5-chlor-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,7]oxepino[4,5-c]pyrrol DK1710241T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05102742 2005-04-07

Publications (1)

Publication Number Publication Date
DK1710241T3 true DK1710241T3 (da) 2010-03-01

Family

ID=35511130

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06112333.7T DK1710241T3 (da) 2005-04-07 2006-04-06 Intermediatforbindelser til fremstilling af trans-5-chlor-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,7]oxepino[4,5-c]pyrrol

Country Status (28)

Country Link
EP (2) EP2154134B1 (da)
JP (1) JP2008534657A (da)
KR (1) KR20070116973A (da)
CN (2) CN101175741B (da)
AR (1) AR063188A1 (da)
AT (1) ATE447564T1 (da)
AU (1) AU2006231281B2 (da)
BR (1) BRPI0610677A2 (da)
CA (1) CA2603181A1 (da)
CY (1) CY1109722T1 (da)
DE (1) DE602006010132D1 (da)
DK (1) DK1710241T3 (da)
ES (1) ES2333980T3 (da)
HK (1) HK1094800A1 (da)
HR (1) HRP20100031T1 (da)
IL (1) IL186354A0 (da)
MX (1) MX2007012446A (da)
NO (1) NO20075152L (da)
NZ (1) NZ562125A (da)
PL (1) PL1710241T3 (da)
PT (1) PT1710241E (da)
RS (1) RS51341B (da)
RU (1) RU2397164C2 (da)
SI (1) SI1710241T1 (da)
TW (1) TW200716589A (da)
UA (2) UA93043C2 (da)
WO (1) WO2006106136A1 (da)
ZA (2) ZA200708493B (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5027477B2 (ja) * 2005-10-21 2012-09-19 住友化学株式会社 ジベンゾオキセピノピロール化合物およびその中間体の製造方法ならびに新規中間体
TW200817414A (en) * 2006-07-05 2008-04-16 Organon Nv Process for the preparation of asenapine and intermediate products used in said process
CN101563312A (zh) * 2006-12-22 2009-10-21 住友化学株式会社 阿塞那平合成中间体的制备方法
US7875729B2 (en) * 2007-01-05 2011-01-25 Synthon Bv Process for making asenapine
JP5245428B2 (ja) 2007-07-06 2013-07-24 住友化学株式会社 トランス−ジベンゾオキセノピロール化合物の製造方法およびその中間体
CA2710800A1 (en) * 2008-01-04 2009-07-16 N.V. Organon Process for the preparation of asenapine and intermediate products used in said process
TW201113018A (en) 2009-06-24 2011-04-16 Organon Nv Injectable formulations containing asenapine and method of treatment using same
CN101851242B (zh) * 2010-05-25 2013-07-24 上海皓元生物医药科技有限公司 阿塞那平中间体的制备方法
EP2598496B1 (en) 2010-07-29 2014-03-19 Laboratorios Lesvi, S.L. Novel process for the preparation of asenapine
WO2012038975A2 (en) * 2010-09-22 2012-03-29 Msn Laboratories Limited Process for the preparation of (3ars,12brs)-5-chloro-2-methyl-2,3,3a12b-tetrahydro-1hdibenzo[2,3:6,7] oxepino [4,5-c]pyrrole maleate and it's pharmaceutical composition thereof
EP2468751B1 (en) 2010-12-24 2016-03-16 Medichem, S.A. Processes for the preparation of 5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrole
ITMI20110734A1 (it) * 2011-05-02 2012-11-03 Olon Spa Sali cristallini di asenapina
WO2013024492A2 (en) 2011-07-01 2013-02-21 Megafine Pharma (P) Ltd. A process for the preparation of asenapine and novel salts thereof
CN102952144A (zh) * 2011-08-29 2013-03-06 上海华拓医药科技发展股份有限公司 阿森纳平马来酸盐的晶型、制备方法及其药物组合物
WO2013080069A1 (en) * 2011-11-28 2013-06-06 Ranbaxy Laboratories Limited Process for the preparation of asenapine intermediate
CN102746209A (zh) * 2012-06-20 2012-10-24 盛世泰科生物医药技术(苏州)有限公司 一种3-(2-(4-氯苯氧基)苯基)-1-甲基-2,4-二酮的合成方法
CN103965206A (zh) * 2013-01-29 2014-08-06 北京京卫燕康药物研究所有限公司 一种阿色纳品马来酸盐的新晶型及制备方法
CN103113379A (zh) * 2013-03-12 2013-05-22 盛世泰科生物医药技术(苏州)有限公司 阿塞那平马来酸盐的合成工艺
CN103254202A (zh) * 2013-05-19 2013-08-21 甘肃皓天化学科技有限公司 阿塞纳平的制备方法
CN103342707B (zh) * 2013-06-28 2015-09-02 甘肃皓天化学科技有限公司 用于制备阿塞纳平中间体的制备方法
CN104447771A (zh) * 2013-09-12 2015-03-25 天津市汉康医药生物技术有限公司 一种稳定的马来酸阿塞那平化合物
CN103864802B (zh) * 2014-03-31 2016-08-17 四川科伦药业股份有限公司 马来酸阿塞那平的制备方法
CN105693735A (zh) * 2016-01-15 2016-06-22 万特制药(海南)有限公司 马来酸阿塞那平一种制备方法
MX2019007391A (es) 2016-12-20 2019-08-16 Lts Lohmann Therapie Systeme Ag Sistema terapeutico transdermico que contiene asenapina.
EP3558276A1 (en) 2016-12-20 2019-10-30 LTS Lohmann Therapie-Systeme AG Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene
WO2019002204A1 (en) 2017-06-26 2019-01-03 Lts Lohmann Therapie-Systeme Ag TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING ASENAPINE AND SILICONE-TYPE ACRYLIC HYBRID POLYMER
CN109200025A (zh) * 2017-06-29 2019-01-15 哈尔滨莱博通药业有限公司 一种阿森纳平马来酸盐舌下片
WO2019243452A1 (en) 2018-06-20 2019-12-26 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine
CN110183457A (zh) * 2019-06-27 2019-08-30 浙江天顺药业有限公司 一种阿塞那平及其制备方法
CN112194665A (zh) * 2020-10-20 2021-01-08 连云港杰瑞药业有限公司 一种合成阿塞那平中间体的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7605526A (nl) * 1976-05-24 1977-11-28 Akzo Nv Nieuwe tetracyclische derivaten.
HU225051B1 (en) 1994-03-02 2006-05-29 Organon Ireland Ltd Sublingual or buccal pharmaceutical compositions containing trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole
WO1999032108A1 (en) 1997-12-19 1999-07-01 Akzo Nobel N.V. Org-5222 in the treatment of depression

Also Published As

Publication number Publication date
CA2603181A1 (en) 2006-10-12
RU2007141161A (ru) 2009-05-20
ATE447564T1 (de) 2009-11-15
EP1710241A1 (en) 2006-10-11
ZA200708493B (en) 2009-09-30
CN101175741A (zh) 2008-05-07
AR063188A1 (es) 2009-01-14
DE602006010132D1 (de) 2009-12-17
CN101175741B (zh) 2011-06-22
UA93044C2 (en) 2011-01-10
HK1094800A1 (en) 2007-04-13
SI1710241T1 (sl) 2010-02-26
CN1861604A (zh) 2006-11-15
TW200716589A (en) 2007-05-01
EP2154134A1 (en) 2010-02-17
CY1109722T1 (el) 2014-04-09
MX2007012446A (es) 2007-11-07
AU2006231281B2 (en) 2011-04-28
AU2006231281A1 (en) 2006-10-12
PT1710241E (pt) 2009-12-10
EP1710241B1 (en) 2009-11-04
CN1861604B (zh) 2011-08-31
KR20070116973A (ko) 2007-12-11
NO20075152L (no) 2007-11-01
UA93043C2 (ru) 2011-01-10
ES2333980T3 (es) 2010-03-03
RU2397164C2 (ru) 2010-08-20
RS51341B (en) 2011-02-28
JP2008534657A (ja) 2008-08-28
BRPI0610677A2 (pt) 2012-10-30
IL186354A0 (en) 2008-01-20
HRP20100031T1 (hr) 2010-02-28
EP2154134B1 (en) 2012-10-24
NZ562125A (en) 2010-08-27
ZA200708490B (en) 2008-10-29
WO2006106136A1 (en) 2006-10-12
PL1710241T3 (pl) 2010-04-30

Similar Documents

Publication Publication Date Title
DK1710241T3 (da) Intermediatforbindelser til fremstilling af trans-5-chlor-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,7]oxepino[4,5-c]pyrrol
CY2012021I1 (el) Παραγωγα πυρρολο[2,3-β]πυριδινης ως αναστολεις κινασης πρωτεϊνης
DK1828164T3 (da) Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider
DK1778668T3 (da) Fremgangsmåde til fremstilling af dihydropteridion
IL183764A0 (en) Bicyclic pyrrole derivatives
DK1797099T3 (da) Piperidinylamino-thieno[2,3-D]pyrimidinforbindelser
DK1893586T3 (da) Fremgangsmåde til fremstilling af 1-alkyl-3-phenyluraciler
HK1101304A1 (en) Bicyclic anthranilamide derivatives useful as insecticides
DK1756049T3 (da) Fremgangsmåde til fremstilling af 1,4-diphenylazetidinon-derivater
HK1163672A1 (en) Processes for the preparation of compounds
HRP20070429T3 (en) Crystal form of asenapine maleate
DK1846376T3 (da) Fremgangsmåde til fremstilling af 10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepin-5-carboxamid
IL183647A (en) The heterocyclic compounds are converted into 3-ethylidenehydrazino
DK1838683T3 (da) Fremgangsmåde til fremstilling af [1,4,5]-oxadiazepinderivater
NL1030503A1 (nl) Octahydropyrrolo[3,4-c]-pyrroolderivaten.
BRPI0822239A2 (pt) Composto de pirazolo[1,5-a] pirimidina
DK1831223T3 (da) Fremgangsmåde til fremstilling af L-biopterin
DK1667967T3 (da) Fremgangsmåde til fremstilling af 2-oxo-1-pyrrolidin-derivater
DE602005010986D1 (de) Neue pyrrolidin-3,4-dicarbonsäureamidderivate
DK1678135T3 (da) Fremgangsm de til fremstilling af n-amino-substituerede hetorocykliske forbindelser
IL191568A0 (en) Novel process for the preparation of 5-amino-3h-thiazolo[4,5-d]pyrimidin-2-one
DK1912961T3 (da) Fremgangsmåde til fremstilling af bepromolin
EP1928827A4 (en) PYRROLE DERIVATIVES AS THERAPEUTIC AGENTS
HK1105634A1 (en) Heteroatoms-containing tricyclic compounds
DK1937662T3 (da) Fremgangsmåde til fremstilling af duloxetin